{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:34:08Z","timestamp":1784543648346,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today: Proceedings"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.matpr.2022.07.387","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T04:54:03Z","timestamp":1659416043000},"page":"3351-3355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"P7","title":["Interleukin 6: A biomarker for COVID-19 progression"],"prefix":"10.1016","volume":"72","author":[{"given":"El-houcine","family":"Sebbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Choukri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.matpr.2022.07.387_b0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10228","key":"10.1016\/j.matpr.2022.07.387_b0010","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(20)30557-2","article-title":"SARS-CoV-2 is an appropriate name for the new coronavirus","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.matpr.2022.07.387_b0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.chom.2015.09.013","article-title":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease","volume":"18","author":"Wong","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"7798","key":"10.1016\/j.matpr.2022.07.387_b0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.matpr.2022.07.387_b0025","first-page":"1708","article-title":"China medical treatment expert group for Covid-19","volume":"382","author":"Guan","year":"2019","journal-title":"Clin. Charact. Coronavirus Dis."},{"issue":"10223","key":"10.1016\/j.matpr.2022.07.387_b0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10235","key":"10.1016\/j.matpr.2022.07.387_b0035","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.matpr.2022.07.387_b0040","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.matpr.2022.07.387_b0045","doi-asserted-by":"crossref","first-page":"e0238160","DOI":"10.1371\/journal.pone.0238160","article-title":"Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: a meta-analysis of 6320 patients","volume":"15","author":"Elshazli","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.matpr.2022.07.387_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104361","article-title":"The clinical course and its correlated immune status in COVID-19 pneumonia","volume":"127","author":"He","year":"2020","journal-title":"J. Clin. Virol."},{"issue":"7","key":"10.1016\/j.matpr.2022.07.387_b0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1515\/cclm-2020-0285","article-title":"Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.matpr.2022.07.387_b0060","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jmv.25871","article-title":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early","volume":"92","author":"Tan","year":"2020","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.matpr.2022.07.387_b0065","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome","volume":"18","author":"Ranucci","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.matpr.2022.07.387_b0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.revmed.2020.12.014","article-title":"COVID-19: coagulopathie et thrombose","volume":"42","author":"Mezalek","year":"2021","journal-title":"La Rev. M\u00e9decine Interne"},{"issue":"4","key":"10.1016\/j.matpr.2022.07.387_b0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pratan.2020.07.007","article-title":"Coagulopathie associ\u00e9e au COVID-19: les \u00e9l\u00e9ments essentiels pour l\u2019anesth\u00e9siste-r\u00e9animateur","volume":"24","author":"Buisson","year":"2020","journal-title":"Le Prat. en anesth\u00e9sie r\u00e9animation"},{"key":"10.1016\/j.matpr.2022.07.387_b0080","doi-asserted-by":"crossref","unstructured":"J. B. Moore and C. H. June, \u201cCytokine release syndrome in severe COVID-19,\u201d Science (80-.)., vol. 368, no. 6490, pp. 473\u2013474, 2020.","DOI":"10.1126\/science.abb8925"},{"issue":"1","key":"10.1016\/j.matpr.2022.07.387_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.matpr.2022.07.387_b0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11239-020-02224-2","article-title":"COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness","volume":"51","author":"Du","year":"2021","journal-title":"J. Thromb. Thrombol."},{"key":"10.1016\/j.matpr.2022.07.387_b0095","series-title":"Cytokine Storm Syndrome","first-page":"31","article-title":"\u201cClinical features of cytokine storm syndrome\u201d, in Cytokine storm syndrome","author":"Shimizu","year":"2019"},{"issue":"9","key":"10.1016\/j.matpr.2022.07.387_b0100","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/ijms21093330","article-title":"Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity","volume":"21","author":"Picchianti Diamanti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.matpr.2022.07.387_b0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.matpr.2022.07.387_b0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12291-021-00989-8","article-title":"Interleukin-6 perpetrator of the COVID-19 cytokine storm","volume":"36","author":"Shekhawat","year":"2021","journal-title":"Indian J. Clin. Biochem."},{"issue":"7","key":"10.1016\/j.matpr.2022.07.387_b0115","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jmv.25770","article-title":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19","volume":"92","author":"Gao","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.matpr.2022.07.387_b0120","article-title":"Baseline Interleukin-6 level predicts risk of severe COVID-19: a two-center","author":"Zhu","year":"2020","journal-title":"Retrospective Study"},{"issue":"4","key":"10.1016\/j.matpr.2022.07.387_b0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/10641963.2020.1867160","article-title":"Association of ACEI\/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19","volume":"43","author":"Xiang","year":"2021","journal-title":"Clin. Exp. Hypertens."},{"issue":"18","key":"10.1016\/j.matpr.2022.07.387_b0130","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/S0735-1097(21)04498-3","article-title":"Elevated Interleukin-6 levels in COVID-19-infected patients are associated with major adverse cardiac events and\/or mortality","volume":"77","author":"Nguyen","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.matpr.2022.07.387_b0135","doi-asserted-by":"crossref","first-page":"e000379","DOI":"10.1136\/bmjdrc-2016-000379","article-title":"Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy","volume":"5","author":"Richard","year":"2017","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"4","key":"10.1016\/j.matpr.2022.07.387_b0140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12291-020-00909-2","article-title":"Obesity and COVID-19: a fatal alliance","volume":"35","author":"Banerjee","year":"2020","journal-title":"Indian J. Clin. Biochem."},{"issue":"2","key":"10.1016\/j.matpr.2022.07.387_b0145","doi-asserted-by":"crossref","first-page":"e0247060","DOI":"10.1371\/journal.pone.0247060","article-title":"Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation","volume":"16","author":"Baker","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.matpr.2022.07.387_b0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jinf.2019.08.014","article-title":"Cigarette smoking and the occurrence of influenza\u2013systematic review","volume":"79","author":"Lawrence","year":"2019","journal-title":"J. Infect."},{"issue":"10","key":"10.1016\/j.matpr.2022.07.387_b0155","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/jmv.25889","article-title":"The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis","volume":"92","author":"Zhao","year":"2020","journal-title":"J. Med. Virol."},{"issue":"4-5","key":"10.1016\/j.matpr.2022.07.387_b0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.micinf.2020.05.007","article-title":"Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"22","author":"Lv","year":"2020","journal-title":"Microbes Infect."},{"key":"10.1016\/j.matpr.2022.07.387_b0165","unstructured":"L. Chen et al., \u201cAnalysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia,\u201d Zhonghua jie he he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese J. Tuberc. Respir. Dis., vol. 43, pp. E005\u2013E005, 2020"},{"key":"10.1016\/j.matpr.2022.07.387_b0170","article-title":"The potential role of IL-6 in monitoring severe cases of coronavirus disease","author":"Liu","year":"2019","journal-title":"MedRxiv"},{"key":"10.1016\/j.matpr.2022.07.387_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.matpr.2022.07.387_b0180","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.matpr.2022.07.387_b0185","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"8","key":"10.1016\/j.matpr.2022.07.387_b0190","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/microorganisms8081097","article-title":"Evaluation of current therapies for COVID-19 treatment","volume":"8","author":"Sethi","year":"2020","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.matpr.2022.07.387_b0195","article-title":"Therapeutic management of patients with COVID-19: a systematic review","volume":"2","author":"Tobaiqy","year":"2020","journal-title":"Infect. Prev. Pract."},{"issue":"1","key":"10.1016\/j.matpr.2022.07.387_b0200","first-page":"10","article-title":"Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)","volume":"38","author":"Shanmugaraj","year":"2020","journal-title":"Asian Pacific J. Allergy Immunol."},{"issue":"20","key":"10.1016\/j.matpr.2022.07.387_b0205","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.matpr.2022.07.387_b0210","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.matpr.2022.07.387_b0215","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.transproceed.2020.06.003","article-title":"Successful treatment of severe COVID-19 pneumonia with clazakizumab in a heart transplant recipient: a case report","volume":"52","author":"Vaidya","year":"2020","journal-title":"Transplant. Proc."},{"issue":"10","key":"10.1016\/j.matpr.2022.07.387_b0220","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/art.39249","article-title":"The efficacy and safety of subcutaneous clazakizumab in patients with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate: results from a multinational, phase IIb, randomized, double-blind, placebo\/active-controlled, dose-ra","volume":"67","author":"Weinblatt","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.matpr.2022.07.387_b0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/RHU.0000000000000583","article-title":"\u201cA systematic review and meta-analysis of efficacy and safety of novel interleukin inhibitors in the management of psoriatic arthritis\u201d","volume":"24","author":"Bilal","year":"2018","journal-title":"JCR J. Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.matpr.2022.07.387_b0230","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ccr3.281","article-title":"The impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasms","volume":"3","author":"Bj\u00f8rn","year":"2015","journal-title":"Clin. Case Reports"},{"issue":"1","key":"10.1016\/j.matpr.2022.07.387_b0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaci.2020.05.019","article-title":"Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single-blind, randomized controlled trial","volume":"146","author":"Cao","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.matpr.2022.07.387_b0240","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrrheum.2017.23","article-title":"The emerging safety profile of JAK inhibitors in rheumatic disease","volume":"13","author":"Winthrop","year":"2017","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["Materials Today: Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214785322050763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214785322050763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T03:25:46Z","timestamp":1762399546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214785322050763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":48,"alternative-id":["S2214785322050763"],"URL":"https:\/\/doi.org\/10.1016\/j.matpr.2022.07.387","relation":{},"ISSN":["2214-7853"],"issn-type":[{"value":"2214-7853","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 6: A biomarker for COVID-19 progression","name":"articletitle","label":"Article Title"},{"value":"Materials Today: Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.matpr.2022.07.387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 Elsevier Ltd. All rights reserved. Selection and peer-review under responsibility of the scientific committee of the Fifth edition of the International Conference on Materials & Environmental Science.","name":"copyright","label":"Copyright"}]}}